Molecular Signatures That Predict Response to Azacitidine Treatment for Myelodysplastic Syndromes

BLOOD

AMER SOC HEMATOLOGY

1. Nippon Shinyaku
2. Chugai Pharmaceutical Co., Ltd.
3. Astellas Pharma Inc.
4. MSD K.K.
5. Kyowa Hakko Kirin Co., Ltd.
6. Zenyaku Kogyo Co., Ltd.
7. Nippon Shinyaku Co., Ltd.
8. Meiji Seika Pharma Co., Ltd.
9. Phizer Japan Inc.
10. Takeda Pharmaceutical Co., Ltd.
11. Novartis Pharma K.K.
12. Sumitomo Dainippon Pharma Co., Ltd.
13. Celgene Corporation
14. Bristol-Myers Squibb
15. JCR Pharmaceuticals Co., Ltd.
16. FUJIFILM Corporation
17. Eisai Co., Ltd.
18. Nippon Boehringer Ingelheim Co., Ltd.
19. ONO Pharmaceutical Co., Ltd.
20. Celegen KK
21. Novartis pharma KK
22. Bristol-Myers Squibb KK
23. Jansen pharmaceutical KK
24. Phizer KK
25. Chugai pharmaceutical KK
26. Dainippon Sumitomo KK
27. Yasuda Medical Foundation